CRB Inverbio leads €4m round for Iden Biotechnology

CRB invested €3m in the round with capital drawn from CRB Bio II, a €60m vehicle launched in 2010. Sodena, the investment instrument of the Navarra region, also contributed €1m.

The fresh capital will enable Iden to add to its team, as well as expand its research and development laboratories in Navarra.

Following completion of the deal, CRB is now the company's largest backer.

Company
Founded in 2005 and headquartered in Noáin, in the Navarra region of northern Spain, Iden is a biotechnology company focusing on the agro-biochemical, pharmaceutical and energy sectors. The business also provides an intermediary platform intended to facilitate contacts between research laboratories and the commercial sector.

People
Angel Santos, a partner at CRB, has taken on the role of president at Iden. Nora Alonso is the company's co-founder and CEO.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Technology
• Southern Europe
• Spain